| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &COO | Chief Operating Officer
1 company
Dowden Nathan J is a President &COO at Entrada Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 25, 2022 | TRDA Entrada Therapeutics, Inc. | Chief Operating Officer | Sell | 9,348 | $20.77 | $194,191.03 | -5.9% | -32.4% | -34.4% | |
| Oct 24, 2022 | TRDA Entrada Therapeutics, Inc. | Chief Operating Officer | Sell | 6,080 | $18.66 | $113,426.11 | -2.5% | -28.8% | -19.9% | |
| Sep 26, 2022 | TRDA Entrada Therapeutics, Inc. | Chief Operating Officer | Sell | 1,544 | $15.45 | $23,853.54 | -1.2% | +1.7% | +0.4% | |
| Sep 23, 2022 | TRDA Entrada Therapeutics, Inc. | Chief Operating Officer | Sell | 4,293 | $15.11 | $64,877.64 | -3.2% | +1.8% | -4.4% | |
| Sep 15, 2022 | TRDA Entrada Therapeutics, Inc. | Chief Operating Officer | Sell | 100 | $15.01 | $1,501.00 | -0.1% | +38.9% | +15.2% | |
| Sep 9, 2022 | TRDA Entrada Therapeutics, Inc. | Chief Operating Officer | Sell | 1,777 | $15.11 | $26,845.13 | -1.3% | +40.8% | -4.5% | |
| Jun 27, 2022 | TRDA Entrada Therapeutics, Inc. | Chief Operating Officer | Sell | 7,714 | $13.00 | $100,282.00 | -10.6% | +19.2% | -1.3% |